Cargando…

Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review

BACKGROUND: Cervical cancer poses a huge health burden, both to developed and developing nations, making prevention and control strategies necessary. However, the challenges of designing and implementing prevention strategies differ for low- and middle-income countries (LMICs) as compared to countri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekwunife, Obinna I., Grote, Andreas Gerber, Mosch, Christoph, O’Mahony, James F., Lhachimi, Stefan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489355/ https://www.ncbi.nlm.nih.gov/pubmed/25963745 http://dx.doi.org/10.1186/s13643-015-0057-8

Ejemplares similares

Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
por: Ekwunife, Obinna I., et al.
Publicado: (2016)

Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage
por: Ekwunife, Obinna I., et al.
Publicado: (2017)

Cost-effectiveness analysis of diarrhoea management approaches in Nigeria: A decision analytical model
por: Okafor, Charles E., et al.
Publicado: (2017)

Interventions to increase mammography screening uptake among women living in low-income and middle-income countries: a systematic review
por: Nduka, Ifeoma Jovita, et al.
Publicado: (2023)

Interventions to increase mammography screening uptake among women living in low-income and middle-income countries: a protocol for a systematic review
por: Nduka, Ifeoma Jovita, et al.
Publicado: (2022)

Repurposed therapeutic agents targeting the Ebola virus: a protocol for a systematic review
por: Sweiti, Hussein, et al.
Publicado: (2015)

Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review
por: Sweiti, Hussein, et al.
Publicado: (2017)

Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review
por: Twumwaa, Tagoe Eunice, et al.
Publicado: (2022)

Interventions to increase the uptake and continuation of pre-exposure prophylaxis (PrEP) by adolescent girls and young women at high risk of HIV in low-income and middle-income countries: a scoping review
por: Ekwunife, Obinna Ikechukwu, et al.
Publicado: (2022)

Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost–benefit analysis
por: Okafor, Charles E, et al.
Publicado: (2021)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews
por: Mandrik, O., et al.
Publicado: (2017)

Cost Burden of Rigid Internal Fixation in Craniomaxillofacial Trauma Care in Low‐ and Middle‐Income Countries
por: Shaye, David A., et al.
Publicado: (2023)

Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia
por: Toh, Zheng Quan, et al.
Publicado: (2017)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis
por: Ekwunife, Obinna Ikechukwu, et al.
Publicado: (2013)

Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening
por: Mandrik, Olena, et al.
Publicado: (2019)

What is the minimum number of specialist anaesthetists needed in low-income and middle-income countries?
por: Davies, Justine I, et al.
Publicado: (2018)

Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study
por: Umeh, Ifeoma Blessing, et al.
Publicado: (2016)

Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013
por: Ladner, Joël, et al.
Publicado: (2014)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives
por: Guillaume, Dominique, et al.
Publicado: (2022)

What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis
por: Russell, Louise B., et al.
Publicado: (2016)

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021)

Responding to Autism in Low and Middle Income Countries (Lmic): What to Do and What Not to Do
por: McConkey, Roy
Publicado: (2022)

The challenges of asthma care in low- and middle-income countries: what’s next?
por: Pitrez, Paulo Márcio
Publicado: (2023)

Community gardening, community farming and other local community-based gardening interventions to prevent overweight and obesity in high-income and middle-income countries: protocol for a systematic review
por: Heise, Thomas L, et al.
Publicado: (2017)

HPV Self-Sampling for Cervical Cancer Screening among Women Living with HIV in Low- and Middle-Income Countries: What Do We Know and What Can Be Done?
por: Asare, Matthew, et al.
Publicado: (2022)

COMMUNICATING THE PARAMETER UNCERTAINTY IN THE IQWIG EFFICIENCY FRONTIER TO DECISION-MAKERS
por: Stollenwerk, Björn, et al.
Publicado: (2015)

A Systematic Review of the Cost-Effectiveness of Cleft Care in Low- and Middle-Income Countries: What is Needed?
por: Chung, Karen Y., et al.
Publicado: (2022)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?
por: Griffiths, Ulla Kou, et al.
Publicado: (2016)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

To what extent can telerehabilitation help patients in low- and middle-income countries?
por: Fernandes, Lívia G., et al.
Publicado: (2021)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country
por: Vale, Diama Bhadra, et al.
Publicado: (2021)

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects()
por: Wigle, Jannah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qoev54fi16sqv7j4nsnhc6bgnm